NVNT / Novint Technologies Inc - Arquivamentos da SEC, Relatório Anual, Declaração de Procuração

Novint Technologies Inc
US ˙ OTC
ESTE SÍMBOLO NÃO ESTÁ MAIS ATIVO

Estatísticas Básicas
CIK 1282980
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Novint Technologies Inc
SEC Filings (Chronological Order)
Esta página fornece uma lista completa e cronológica de Arquivamentos da SEC, excluindo os arquivamentos de propriedade que fornecemos em outro lugar.
May 13, 2026 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 ☐ TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 Dror Ortho-De

May 1, 2026 EX-4.2

COMMON STOCK PURCHASE WARRANT dror ortho-design, INC.

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

May 1, 2026 EX-4.1

DEBENTURE DUE JUNE 28, 2026

Exhibit 4.1 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAI

May 1, 2026 EX-10.1

SECURITIES PURCHASE AGREEMENT

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of April 28, 2026, among Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), and each investor listed on the signature pages hereto (including its successors and assigns, each a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and conditions set fo

May 1, 2026 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2026 Dror Ortho-Design,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2026 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission File

April 1, 2026 EX-4.18

UNDERWRITER’S PURCHASE WARRANT Dror Ortho-Design, INC.

EXHIBIT 4.18 THE REGISTERED HOLDER OF THIS SECURITY AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS SECURITY FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE DATE OF THE UNDERWRITING AGREEMENT (DEFINED BELOW) TO ANYONE OTHER THAN (I) AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER, PARTNER OR AFFILIATE OF AMERICAN CAP

April 1, 2026 EX-FILING FEES

CALCULATION OF FILING FEE TABLES Dror Ortho-Design, Inc. Table 1: Newly Registered and Carry Forward Securities

Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-1 Dror Ortho-Design, Inc. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Common Stock,

April 1, 2026 S-1/A

As filed with the Securities and Exchange Commission on April 1, 2026

As filed with the Securities and Exchange Commission on April 1, 2026 Registration No.

April 1, 2026 EX-4.17

PRE-FUNDED COMMON STOCK PURCHASE WARRANT Dror Ortho-Design, Inc.

Exhibit 4.17 PRE-FUNDED COMMON STOCK PURCHASE WARRANT Dror Ortho-Design, Inc. Warrant Shares: 1 Initial Exercise Date: , 20262 Issue Date: , 2026 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time o

April 1, 2026 EX-1.1

DROR ORTHO-DESIGN, INC. [ ] SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE PRE-FUNDED WARRANTS TO PURCHASE [ ] SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE Underwriting Agreement

Exhibit 1.1 DROR ORTHO-DESIGN, INC. [ ] SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE PRE-FUNDED WARRANTS TO PURCHASE [ ] SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE Underwriting Agreement . [MONTH] [DAY], 2026 Titan Partners Group LLC, a division of American Capital Partners, LLC As the Representative of the several Underwriters listed in Schedule A hereto c/o Titan Partners Group L

March 4, 2026 EX-4.1

DEBENTURE DUE APRIL 27, 2026

Exhibit 4.1 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAI

March 4, 2026 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2026 Dror Ortho-Desi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2026 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission F

March 4, 2026 EX-4.2

COMMON STOCK PURCHASE WARRANT dror ortho-design, INC.

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

March 4, 2026 EX-10.1

SECURITIES PURCHASE AGREEMENT

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of February 26, 2026, among Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), and each investor listed on the signature pages hereto (including its successors and assigns, each a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and conditions set

February 27, 2026 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 Dror Ortho-Design,

February 3, 2026 S-1/A

As filed with the Securities and Exchange Commission on February 2, 2026

As filed with the Securities and Exchange Commission on February 2, 2026 Registration No.

February 3, 2026 EX-4.16

UNDERWRITER’S PURCHASE WARRANT Dror Ortho-Design, INC.

EXHIBIT 4.16 THE REGISTERED HOLDER OF THIS SECURITY AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS SECURITY FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE DATE OF THE UNDERWRITING AGREEMENT (DEFINED BELOW) TO ANYONE OTHER THAN (I) AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER, PARTNER OR AFFILIATE OF AMERICAN CAP

February 3, 2026 EX-1.1

DROR ORTHO-DESIGN, INC. [ ] SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE PRE-FUNDED WARRANTS TO PURCHASE [ ] SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE Underwriting Agreement

Exhibit 1.1 DROR ORTHO-DESIGN, INC. [ ] SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE PRE-FUNDED WARRANTS TO PURCHASE [ ] SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE Underwriting Agreement [MONTH] [DAY], 2026 Titan Partners Group LLC, a division of American Capital Partners, LLC As the Representative of the several Underwriters listed in Schedule A hereto c/o Titan Partners Group LLC

February 3, 2026 EX-4.15

PRE-FUNDED COMMON STOCK PURCHASE WARRANT Dror Ortho-Design, Inc.

Exhibit 4.15 PRE-FUNDED COMMON STOCK PURCHASE WARRANT Dror Ortho-Design, Inc. Warrant Shares: 1 Initial Exercise Date: , 20262 Issue Date: , 2026 THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time o

January 6, 2026 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2025 Dror Ortho-Desi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 30, 2025 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission F

January 6, 2026 EX-4.1

DEBENTURE DUE FEBURARY 28, 2026

Exhibit 4.1 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAI

January 6, 2026 EX-4.2

COMMON STOCK PURCHASE WARRANT dror ortho-design, INC.

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

January 6, 2026 EX-10.1

SECURITIES PURCHASE AGREEMENT

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 30, 2025, among Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), and each investor listed on the signature pages hereto (including its successors and assigns, each a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and conditions set

December 8, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2025 Dror Ortho-Desig

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2025 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission Fi

December 8, 2025 EX-4.1

DEBENTURE DUE FEBURARY 2, 2026

Exhibit 4.1 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAI

December 8, 2025 EX-4.2

COMMON STOCK PURCHASE WARRANT dror ortho-design, INC.

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

December 8, 2025 EX-10.1

SECURITIES PURCHASE AGREEMENT

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 2, 2025, among Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), and each investor listed on the signature pages hereto (including its successors and assigns, each a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and conditions set

November 18, 2025 EX-10.1

SECURITIES PURCHASE AGREEMENT

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of November 12, 2025, among Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), and each investor listed on the signature pages hereto (including its successors and assigns, each a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and conditions set

November 18, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 Dror Orth

November 18, 2025 EX-4.2

COMMON STOCK PURCHASE WARRANT dror ortho-design, INC.

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

November 18, 2025 EX-4.1

DEBENTURE DUE JANUARY 12, 2026

Exhibit 4.1 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAI

November 17, 2025 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition P

August 14, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 Dror Ortho-Des

July 23, 2025 EX-4.1

Form of Debenture, issued on July 17, 2025.

Exhibit 4.1 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAI

July 23, 2025 EX-4.2

Form of Warrant.

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

July 23, 2025 EX-10.1

Securities Purchase Agreement, dated July 17, 2025, by and among the Company and the investors signatory thereto.

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of July 17, 2025, among Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), and each investor listed on the signature pages hereto (including its successors and assigns, each a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and conditions set for

July 23, 2025 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2025 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission File

July 14, 2025 S-1/A

As filed with the Securities and Exchange Commission on July 14, 2025

As filed with the Securities and Exchange Commission on July 14, 2025 Registration No.

July 14, 2025 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables S-1 (Form Type) Dror Ortho-Design, Inc.

June 25, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2025 Dror Ortho-Design,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2025 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission File

June 20, 2025 DEFR14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Amendment No. 1 to SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Amendment No.

June 18, 2025 EX-4.2

Form of Warrant (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 18, 2025).

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

June 18, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2025 Dror Ortho-Design,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2025 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission File

June 18, 2025 EX-4.1

Form of Debenture, issued on June 16, 2025 (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 18, 2025).

Exhibit 4.1 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAI

June 18, 2025 EX-10.1

Securities Purchase Agreement, dated June 16, 2025, by and among the Company and the investors signatory thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 18, 2025).

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of June 16, 2025, among Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), and each investor listed on the signature pages hereto (including its successors and assigns, each a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and conditions set for

June 10, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2025 Dror Ortho-Design,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2025 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission File

June 10, 2025 PRER14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Amendment No. 1 to SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Amendment No.

June 5, 2025 EX-10.1

Securities Purchase Agreement, dated June 5, 2025, by and among the Company and the investors signatory thereto.

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of June 5, 2025, among Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), and each investor listed on the signature pages hereto (including its successors and assigns, each a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and conditions set fort

June 5, 2025 EX-4.2

Form of Debenture, issued on June 5, 2025 (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 5, 2025).

Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

June 5, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Dror Ortho-Design, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission File N

June 5, 2025 EX-4.1

Form of Debenture, issued on June 5, 2025.

Exhibit 4.1 THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAI

May 28, 2025 EX-FILING FEES

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables S-1 (Form Type) Dror Ortho-Design, Inc.

May 28, 2025 S-1

As filed with the Securities and Exchange Commission on May 28, 2025

As filed with the Securities and Exchange Commission on May 28, 2025 Registration No.

May 21, 2025 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under §240.

May 15, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 Dror Ortho-De

April 10, 2025 DRS

Draft registration statement as confidentially submitted to the U.S. Securities and Exchange Commission on April 10, 2025. This draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all informat

Draft registration statement as confidentially submitted to the U.S. Securities and Exchange Commission on April 10, 2025. This draft registration statement has not been publicly filed with the U.S. Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGIS

February 19, 2025 EX-10.17

Amendment to Personal Employment, dated as of February 18, 2025, effective as of June 30, 2023, by and between Dror Ortho-Design Ltd. and Eliyahu Haddad (incorporated by reference to Exhibit 10.17 to the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on February 19, 2025)

Exhibit 10.17 AMENDMENT TO PERSONAL EMPLOYMENT AGREEMENT This Amendment (the “Amendment”) is entered into on February 18, 2025 by and between Dror Ortho-Design Ltd., reg. no. 513542274 (the “Company”) and Eliyahu Haddad, I.D. no. 328971973 (the “Employee”). WHEREAS, the Company and the Employee have entered into that certain Personal Employment Agreement dated as of December 6, 2021, setting forth

February 19, 2025 EX-10.18

Amendment to Personal Employment, dated as of February 18, 2025, effective as of February 5, 2025, by and between Dror Ortho-Design Ltd. and Eliyahu Haddad (incorporated by reference to Exhibit 10.18 to the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on February 19, 2025)

Exhibit 10.18 AMENDMENT TO PERSONAL EMPLOYMENT AGREEMENT This Amendment (the “Amendment”) is entered into on February 18, 2025 by and between Dror Ortho-Design Ltd., reg. no. 513542274 (the “Company”) and Eliyahu Haddad, I.D. no. 328971973 (the “Employee”). WHEREAS, the Company and the Employee have previously entered into that certain Personal Employment Agreement dated as of December 6, 2021, se

February 19, 2025 EX-10.19

Amendment to Personal Employment, dated as of February 18, 2025, effective as of June 30, 2023, by and between Dror Ortho-Design Ltd. and Moshe Shvets (incorporated by reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on February 19, 2025)

Exhibit 10.19 AMENDMENT TO PERSONAL EMPLOYMENT AGREEMENT This Amendment (the “Amendment”) is entered into on February 18, 2025 by and between Dror Ortho-Design Ltd., reg. no. 513542274 (the “Company”) and Moshe Shvets, I.D. no. 307349373 (the “Employee”). WHEREAS, the Company and the Employee have entered into that certain Personal Employment Agreement dated as of December 6, 2021, setting forth t

February 19, 2025 EX-10.20

Amendment to Personal Employment, dated as of February 18, 2025, effective as of February 5, 2025, by and between Dror Ortho-Design Ltd. and Moshe Shvets (incorporated by reference to Exhibit 10.20 to the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on February 19, 2025)

Exhibit 10.20 AMENDMENT TO PERSONAL EMPLOYMENT AGREEMENT This Amendment (the “Amendment”) is entered into on February 18, 2025 by and between Dror Ortho-Design Ltd., reg. no. 513542274 (the “Company”) and Moshe Shvets, I.D. no. 07349373 (the “Employee”). WHEREAS, the Company and the Employee have previously entered into that certain Personal Employment Agreement dated as of January 26, 2022, setti

February 19, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 Dror Ortho-Design,

November 14, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 Dror Orth

August 14, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 Dror Ortho-Des

June 17, 2024 424B3

DROR ORTHO-DESIGN, INC. 293,145,818 Shares of Common Stock 1,046,336,224 Shares of Common Stock Underlying Series A Convertible Preferred Stock 474,999,993 Shares of Common Stock Underlying Private Placement Warrants 489,834,426 Shares of Common Stoc

Filed Pursuant to Rule 424(b)(3) Registration No. 333-276981 Prospectus DROR ORTHO-DESIGN, INC. 293,145,818 Shares of Common Stock 1,046,336,224 Shares of Common Stock Underlying Series A Convertible Preferred Stock 474,999,993 Shares of Common Stock Underlying Private Placement Warrants 489,834,426 Shares of Common Stock Underlying Share Exchange Warrants This prospectus relates to the offer and

June 12, 2024 CORRESP

Dror Ortho-Design, Inc. Shatner Street 3 Jerusalem, Israel

Dror Ortho-Design, Inc. Shatner Street 3 Jerusalem, Israel June 12, 2024 VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services U.S. Securities and Exchange Commission Washington, D.C. 20549 Attention: Robert Augustin and Lauren Nguyen Re: Dror Ortho-Design, Inc. Registration Statement on Form S-1 Originally filed on February 9, 2024, as amended on April 17, 2024

June 5, 2024 S-1/A

As filed with the Securities and Exchange Commission on June 5, 2024

As filed with the Securities and Exchange Commission on June 5, 2024 Registration No.

May 20, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 Dror Ortho-De

May 15, 2024 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Perio

May 10, 2024 CORRESP

Dror Ortho-Design, Inc. Shatner Street 3 Jerusalem, Israel

Dror Ortho-Design, Inc. Shatner Street 3 Jerusalem, Israel May 10, 2024 VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services U.S. Securities and Exchange Commission Washington, D.C. 20549 Attention: Robert Augustin and Lauren Nguyen Re: Dror Ortho-Design, Inc. Amendment No. 1 to the Registration Statement on Form S-1/A Originally filed on February 9, 2024, as am

May 3, 2024 LETTER

LETTER

United States securities and exchange commission logo May 3, 2024 Eliyahu Haddad Chief Executive Officer Dror Ortho-Design, Inc.

April 25, 2024 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-5178

April 17, 2024 S-1/A

As filed with the Securities and Exchange Commission on April 17, 2024

As filed with the Securities and Exchange Commission on April 17, 2024 Registration No.

April 17, 2024 CORRESP

Dror Ortho-Design, Inc. Shatner Street 3 Jerusalem, Israel

Dror Ortho-Design, Inc. Shatner Street 3 Jerusalem, Israel April 17, 2024 VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services U.S. Securities and Exchange Commission Washington, D.C. 20549 Attention: Robert Augustin, Lauren Nguyen, Jeanne Bennett, and Matthew Derby Re: Dror Ortho-Design, Inc. Registration Statement on Form S-1 Originally filed on February 9, 20

April 1, 2024 EX-10.16

Services Agreement, dated February 7, 2023, between Dror Ortho-Design, Inc. and Chaim Ravad (incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on April 1, 2024)

Exhibit 10.16 SERVICES AGREEMENT This Services Agreement (“Agreement”) is entered into as of this 7 day of February, 2024 by and between Dror Ortho-Design Ltd., an Israeli company, having its principal place of business at3 Shatner Street, Givat Shaul, Jerusalem, Israel, 9546103 (“Company”), and Chaim Ravad, Israeli ID no., [ ], of [ ] (“Service Provider”). WHEREAS, Service Provider represents tha

April 1, 2024 EX-10.15

First Amendment to Services Agreement, dated February 7, 2023, between Dror Ortho-Design, Inc. and Yehuda Englander (incorporated by reference to Exhibit 10.15 to the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on April 1, 2024)

Exhibit 10.15 FIRST AMENDMENT TO SERVICES AGREEMENT This First Amendment to the Services Agreement (as defined below) (“First Amendment”) is entered into as of February 7, 2024, by and Dror-Ortho Design Ltd., a company organized under the laws of the State of Israel (“Company”) and Yehudah Englander, I.D number 035841501 (“Service Provider”). The Company and the Service Provider shall each be refe

April 1, 2024 EX-4.2

Description of Securities (incorporated by reference to Exhibit 4.2 to the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on April 1, 2024).

Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK The following summary of the material terms of the capital stock of Dror Ortho-Design, Inc. (“we,” “our” and the “Company”) is not intended to be a complete summary of the rights and preferences of such securities. The full text of the our certificate of incorporation, as amended (the “Amended Charter”) and our bylaws, as amended (the “Bylaws”) are included

April 1, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 Dror Ortho-Design,

March 5, 2024 LETTER

LETTER

United States securities and exchange commission logo March 5, 2024 Eliyahu Haddad Chief Executive Officer Dror Ortho-Design, Inc.

February 9, 2024 S-1

As filed with the Securities and Exchange Commission on February 9, 2024

As filed with the Securities and Exchange Commission on February 9, 2024 Registration No.

February 9, 2024 EX-21.1

List of Subsidiaries (incorporated by reference to Exhibit 21.1 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on February 9, 2024).

Dror Ortho-Design, Inc. S-1 Exhibit 21.1 Subsidiaries of Dror Ortho-Design, Inc. (as of February 6, 2024) Company Jurisdiction Dror Ortho-Design, Ltd. Israel

February 9, 2024 EX-FILING FEES

Filing Fee Table

Dror Ortho-Design, Inc. S-1 Exhibit 107 Calculation of Filing Fee Tables Form S-1 Dror Ortho-Design, Inc. Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees t

January 10, 2024 SC 13G/A

DROR / Dror Ortho-Design, Inc. / ALPHA CAPITAL ANSTALT - AMENDMENT NO. 3 TO SCHEDULE 13G Passive Investment

SC 13G/A 1 ea191458-13ga3alphadror.htm AMENDMENT NO. 3 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 3) DROR ORTHO-DESIGN, INC. f/k/a NOVINT TECHNOLOGIES, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 (Title of Class of Securities) 670085109 (CUSIP Number) December 31, 2023 (DA

January 4, 2024 EX-3.1

Amended and Restated Certificate of Incorporation of Dror Ortho-Design, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on January 4, 2024)

Dror Ortho-Design, Inc. FORM 8-K Exhibit 3.1 Amended and Restated Certificate of Incorporation of Dror Ortho-Design, Inc. Pursuant to Sections 242 and 245 of the Delaware General Corporation Law Dror Ortho-Design, Inc. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify that: 1. The present name of t

January 4, 2024 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 29, 2023 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission F

December 18, 2023 ARS

ANNUAL REPORT TO SECURITY HOLDERS

DROR ORTHO-DESIGN, INC. 2022 Annual Report to Stockholders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ց Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2022 տ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period

December 18, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under §240.

December 8, 2023 PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☐ Definitive Additional Materials ☐ Soliciting Material under §240.

November 20, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 Dror Orth

November 14, 2023 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2023 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission Fi

November 14, 2023 EX-3.1

Second Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on November 14, 2023)

Dror Ortho-Design Ltd. 8-K/A Exhibit 3.1 Second Amended and Restated Bylaws of Dror Ortho-Design, Inc. a Delaware Corporation (Effective as of October 24, 2023) TABLE OF CONTENTS Page ARTICLE I — CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 1.2 OTHER OFFICES 1 ARTICLE II — MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL MEETING 1 2.4 ADVANCE NOTICE PROCEDURES 2 2

November 14, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition P

November 14, 2023 8-K/A

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2023 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorpora

November 14, 2023 EX-3.1

Certificate of Correction to the Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock of Dror Ortho-Design, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the Commission on November 14, 2023)

Dror Ortho-Design Ltd. 8-K Exhibit 3.1 CERTIFICATE OF CORRECTION OF Dror Ortho-Design, Inc., a Delaware corporation Dror Ortho-Design, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”) hereby certifies: 1. The name of the Corporation is Dror Ortho-Design, Inc. 2. That the Certificate of Designation of Preferen

October 24, 2023 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2023 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission Fi

October 24, 2023 EX-16.1

Letter from Sadler, Gibb & Associates, LLC to the Securities and Exchange Commission dated October 20, 2023 (incorporated by reference to Exhibit 16.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on October 24, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 16.1 October 20, 2023 Securities and Exchange Commission 100 F Street, N.W. Washington, D.C. 20549-7561 Ladies and Gentlemen, We have read the statements of Dror Orthro-Design, Inc. (FKA:Novint Technologies, Inc.) relating to the event described under Item 4.01 of Form 8-K dated October 18, 2023 and we agree with such statements as they pertain to our firm. Resp

September 20, 2023 SC 13G

NVNT / Novint Technologies Inc / HIRSCHMAN ORIN Passive Investment

SC 13G 1 formsc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Dror Ortho-Design, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 670085109 (CUSIP Number) August 14, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate

September 18, 2023 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2023 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission

August 18, 2023 EX-10.14

Services Agreement, dated June 1, 2022, between Dror Ortho-Design Ltd. and Yehuda Englander (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K/A filed with the Securities and Exchange Commission on August 18, 2023)

Dror Ortho-Design Ltd. 8-K/A Exhibit 10.14 SERVICES AGREEMENT This Services Agreement (“Agreement”) is entered into as of this 01 day of June, 2022 by and between Dror Ortho- Design Ltd., an Israeli company513542274 having its principal place of business at 3 Shatner Street, Givat Shaul, Jerusalem, Israel, 9546103 [email protected] (“Company”), and Yehudah Englander, Israeli ID no., [035841501

August 18, 2023 8-K/A

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2023 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporat

August 14, 2023 EX-10.12

Securities Purchase Agreement, dated August 14, 2023, between the Company and certain purchasers identified therein (incorporated by reference to Exhibit 10.11 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.11 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of July , 2023, between Novint Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subjec

August 14, 2023 EX-10.2

Employment Agreement, dated January 26, 2022, between the Company and Moshe Shvets (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.2 PERSONAL EMPLOYMENT AGREEMENT This Personal Employment Agreement (the “Agreement”) is entered into this 26 of January , 2022 by and between Dror Ortho Design Ltd., reg. no. 513542274, a company organized under the laws of the State of Israel, having its principal place of business at 3 Shatner Streat, Jerusalem (the “Company”) and the employee whose details

August 14, 2023 EX-99.3

NOVINT TECHNOLOGIES, INC. PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF MARCH 31, 2023

Dror Ortho-Design, Inc. 8-K Exhibit 99.3 NOVINT TECHNOLOGIES, INC. PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF MARCH 31, 2023 (UNAUDITED) On July 5, 2023, Novint Technologies, Inc. (“Novint” the “Company”) entered into a Share Exchange Agreement (as amended, the “Exchange Agreement”) by and among Novint, Dror Ortho-Design Ltd., a company incorporated under the laws of the State of

August 14, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 NOVINT TECHNOL

August 14, 2023 EX-10.1

Employment Agreement, dated December 6, 2021, between the Company and Eliyahu (Lee) Haddad (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.1 Employment Agreement This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of December 6, 2021, by and between Dror Ortho-Design Ltd. registration No. 513542274 (the “Company”), and Lee Haddad ID No.: 328971973(“Executive”). WHEREAS, the Executive is expected to make major contributions to the stability, growth and financial strength of the Company

August 14, 2023 EX-10.13

Registration Rights Agreement, dated August 14, 2023, between the Company and certain purchasers identified therein (incorporated by reference to Exhibit 10.12 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.12 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of June , 2023, between Novint Technologies, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement is made pursua

August 14, 2023 EX-99.2

DROR ORTHO-DESIGN LTD. FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2023 DROR ORTHO-DESIGN LTD FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2023 INDEX TO FINANCIAL STATEMENTS

Dror Ortho-Design, Inc. 8-K Exhibit 99.2 DROR ORTHO-DESIGN LTD. FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2023 DROR ORTHO-DESIGN LTD FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2023 INDEX TO FINANCIAL STATEMENTS TABLE OF CONTENTS Review Report of Independent Registered Public Accounting Firm (PCAOB ID: 2015) 2 Balance Sheets 3 Statements of Operations 4 Statements of

August 14, 2023 EX-2.2

Amendment to the Share Exchange Agreement, dated August 14, 2023, by and among the Company, Dror Ortho-Design Ltd., and certain shareholders of Dror Ortho-Design Ltd. (incorporated by reference to Exhibit 2.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 2.2 Amendment To Share Exchange Agreement This Amendment to Share Exchange Agreement (this “Amendment”), dated as of July [●], 2023, is by and among Novint Technologies, Inc., a Delaware corporation (the “Parent”), Dror Ortho-Design Ltd., a company incorporated under the laws of the state of Israel (the “Company”), and the shareholders of the Company that are si

August 14, 2023 EX-4.1

Form of Class A Common Stock Purchase Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURS

August 14, 2023 EX-10.7

Indemnification Agreement, dated December 6, 2021, between Dror Ortho-Design Ltd. and Yehuda Englander (incorporated by reference to Exhibit 10.7 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.7 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the “Agreement”), dated as of December 6, 2021, is entered into by and between Dror Ortho-Design Ltd., an Israeli company (the “Company”), and the undersigned Director or Officer of the Company whose name appears on the signature page hereto (the “Indemnitee”). WHEREAS, Indemnitee is an Office Holder

August 14, 2023 8-K

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2023 Dror Ortho-Design, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission Fil

August 14, 2023 EX-10.6

Indemnification Agreement, dated December 6, 2021, between Dror Ortho-Design Ltd. and Chaim Ravad (incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.6 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the “Agreement”), dated as of December 6, 2021, entered into by and between Dror Ortho-Design Listd., an Israeli company (the “Company”), and the undersigned Director or Officer of the Company whose name appears on the signature page hereto (the “Indemnitee”). WHEREAS, Indemnitee is an Office Holder

August 14, 2023 EX-10.5

Indemnification Agreement, dated December 6, 2021, between Dror Ortho-Design Ltd. and Chaim Hurvitz (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.5 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the “Agreement”), dated as of December 6, 2021, entered into by and between Dror Ortho-Design Listd., an Israeli company (the “Company”), and the undersigned Director or Officer of the Company whose name appears on the signature page hereto (the “Indemnitee”). WHEREAS, Indemnitee is an Office Holder

August 14, 2023 EX-10.14

Form of Lock-Up Agreement (incorporated by reference to Exhibit 10.13 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.13 LOCK-UP AGREEMENT , 2023 Ladies and Gentlemen: Defined terms not otherwise defined in this letter agreement (the “Lock-Up Agreement”) shall have the meanings set forth in the Share Exchange Agreement (the “Share Exchange Agreement”), dated as of , 2023, between Novint Technologies, Inc., a Delaware corporation (the “Parent”), Dror Ortho-Design Ltd., a comp

August 14, 2023 EX-10.10

2021 Share Incentive Plan (incorporated by reference to Exhibit 10.9 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.9 DROR ORTHO DESIGN LTD. 2021 SHARE INCENTIVE PLAN Unless otherwise defined, terms used herein shall have the meaning ascribed to them in Section 2 hereof. 1. PURPOSE; TYPES OF AWARDS; CONSTRUCTION. 1.1. Purpose. The purpose of this 2021 Share Incentive Plan (this “Plan") is to afford an incentive to Service Providers of Dror Ortho Design Ltd., an Israeli com

August 14, 2023 EX-10.8

Consulting Agreement, dated December 6, 2021, between Dror Ortho-Design Ltd. and Yaacov Bodner (incorporated by reference to Exhibit 10.8 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.8 CONSULTING AGREEMENT THIS AGREEMENT is entered into as of the 6 day of December, 2021, by and between DROR ORTHO DESIGN LIMITED, a company incorporated under the laws of the State of Israel, having its principal place of business at3 Shatner Street, Givat Shaul, Jerusalem, Israel, 9546103, [email protected] (“Company”), and YAAKOV BODNER (“Consultant”).

August 14, 2023 EX-10.3

Indemnification Agreement, dated December 6, 2021, between Dror Ortho-Design Ltd. and Eliyahu (Lee) Haddad (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.3 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the “Agreement”), dated as of December 6, 2021, entered into by and between Dror Ortho-Design Listd., an Israeli company (the “Company”), and the undersigned Director or Officer of the Company whose name appears on the signature page hereto (the “Indemnitee”). WHEREAS, Indemnitee is an Office Holder

August 14, 2023 EX-10.4

Indemnification Agreement, dated December 6, 2021, between Dror Ortho-Design Ltd. and Moshe Shvets (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 10.4 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT (the “Agreement”), dated as of December 6, 2021, entered into by and between Dror Ortho-Design Listd., an Israeli company (the “Company”), and the undersigned Director or Officer of the Company whose name appears on the signature page hereto (the “Indemnitee”). WHEREAS, Indemnitee is an Office Holder

August 14, 2023 EX-3.1

Amended and Restated Certificate of Incorporation of Dror Ortho-Design, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 3.1 Amended and Restated Certificate of Incorporation of Novint Technologies, Inc. Pursuant to Sections 242 and 245 of the Delaware General Corporation Law Novint Technologies, Inc. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify that: 1. The present name of th

August 14, 2023 EX-3.2

Certificate of Designations of Preferences, Rights and Limitations of Series A Convertible Preferred Stock (incorporated by reference to Exhibit 3.2 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 3.2 EXHIBIT G NOVINT TECHNOLOGIES, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Orin Hirschman, does hereby certify that: 1. They are the President and Secretary, respectively, of Novint Technologies, Inc., a Delaware

August 14, 2023 EX-2.1

Share Exchange Agreement, dated July 5, 2023, by and among the Company, Dror Ortho-Design Ltd., and certain shareholders of Dror Ortho-Design Ltd. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on August 14, 2023)

Dror Ortho-Design, Inc. 8-K Exhibit 2.1 SHARE EXCHANGE AGREEMENT This Share Exchange Agreement (this “Agreement”), dated as of July 5, 2023, is by and among Novint Technologies, Inc., a Delaware corporation (the “Parent”), Dror Ortho-Design Ltd., a company incorporated under the laws of the state of Israel (the “Company”), and the shareholders of the Company including but not limited to holders of

August 14, 2023 EX-99.1

DROR ORTHO-DESIGN LTD. FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021 DROR ORTHO-DESIGN LTD FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021 INDEX TO FINANCIAL STATEMENTS

Dror Ortho-Design, Inc. 8-K Exhibit 99.1 DROR ORTHO-DESIGN LTD. FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021 DROR ORTHO-DESIGN LTD FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021 INDEX TO FINANCIAL STATEMENTS TABLE OF CONTENTS Report of Independent Registered Public Accounting Firm (PCAOB ID: 2015) 2 Balance Sheets 3 Statements of Operations 4 Statements

August 14, 2023 EX-10.11

2023 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on January 4, 2024)

Dror Ortho-Design, Inc. 8-K Exhibit 10.10 DROR ORTHO-DESIGN, INC. 2023 LONG-TERM INCENTIVE PLAN The Dror Ortho-Design, Inc. 2023 Long-Term Incentive Plan (the “Plan”) was adopted by the Board of Directors of Dror Ortho-Design, Inc., a Delaware corporation (the “Company”), effective as of August 14, 2023 (the “Effective Date”), subject to approval by the Company’s stockholders. Article 1. PURPOSE T

July 11, 2023 EX-2.1

Share Exchange Agreement, dated July 5, 2023, by and among the Company, Dror Ortho-Design Ltd., and certain shareholders of Dror Ortho-Design Ltd.

Novint Technologies, Inc. 8-K Exhibit 2.1 SHARE EXCHANGE AGREEMENT This Share Exchange Agreement (this “Agreement”), dated as of July 5, 2023, is by and among Novint Technologies, Inc., a Delaware corporation (the “Parent”), Dror Ortho-Design Ltd., a company incorporated under the laws of the state of Israel (the “Company”), and the shareholders of the Company including but not limited to holders

July 11, 2023 EX-10.1

Form of Lock-Up Agreement

Novint Technologies, Inc. 8-K Exhibit 10.1 LOCK-UP AGREEMENT , 2023 Ladies and Gentlemen: Defined terms not otherwise defined in this letter agreement (the “Lock-Up Agreement”) shall have the meanings set forth in the Share Exchange Agreement (the “Share Exchange Agreement”), dated as of , 2023, between Novint Technologies, Inc., a Delaware corporation (the “Parent”), Dror Ortho-Design Ltd., a com

July 11, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 5, 2023 Novint Technologies,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 5, 2023 Novint Technologies, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporation) (Commission File

June 23, 2023 SC 13G/A

USAU / U.S. Gold Corp / ALPHA CAPITAL ANSTALT - AMENDMENT NO.2 TO SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2) NOVINT TECHNOLOGIES, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 (Title of Class of Securities) 670085103 (CUSIP Number) March 22, 2021 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) Check the appropriate box to designate the rule pur

May 12, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 NOVINT TECHNO

March 31, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2022 ☐ Transition Report Pursua

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2022 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-51783 NOVINT TECHNOLOGIES,

November 14, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 NOVINT TE

August 12, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 NOVINT TECHNOL

May 13, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 NOVINT TECHNO

March 23, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2021 ☐ Transition Report Pursua

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2021 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-51783 NOVINT TECHNOLOGIES,

January 31, 2022 SC 13G/A

USAU / U.S. Gold Corp. / ALPHA CAPITAL ANSTALT - AMENDMENT NO.1 TO SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1) NOVINT TECHNOLOGIES, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 (Title of Class of Securities) 670085103 (CUSIP Number) December 31, 2021 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) Check the appropriate box to designate the rule

November 12, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 NOVINT TE

August 12, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 NOVINT TECHNOL

May 21, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

10-Q 1 nvnt-10q033121.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to

May 17, 2021 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N -SAR ☐ Form N-CSR ☐ For Period Ended: ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR Fo

March 24, 2021 10-K

Annual Report - ANNUAL REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ? Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2020 ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-51783 NOVINT TECHNOLOGIES,

March 24, 2021 SC 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. __) NOVINT TECHNOLOGIES, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 (Title of Class of Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) NOVINT TECHNOLOGIES, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.0001 (Title of Class of Securities) 670085103 (CUSIP Number) March 22, 2021 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) Check the appropriate box to designate the rule pursua

November 13, 2020 10-Q

Quarterly Report - QUARTERLY REPORT

10-Q 1 nvnt-10q093020.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from

August 14, 2020 10-Q

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 NOVINT TECHNOL

June 2, 2020 SC 13D

NVNT / Novint Technologies, Inc. / Ellis International L.P. - SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 NOVINT TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 670085103 (CUSIP Number) Ellis International L.P. 100 Merrick Road, Suiter 400W Rockville Centre, NY 11570 (516) 887-6000 (Tel) (Name, Address and Telephone Number of Pers

June 2, 2020 SC 13D

NVNT / Novint Technologies, Inc. / AIGH Investment Partners, LLC - SCHEDULE 13D Activist Investment

SC 13D 1 ea122582-sc13daighnovint.htm SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 NOVINT TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 670085103 (CUSIP Number) AIGH Investment Partners, LLC 6006 Berkeley Ave. Baltimore, MD 21209 (410) 415-6464 (Tel) (Name

May 28, 2020 SC 13D

NVNT / Novint Technologies, Inc. / Congregation Ahavas Tzdokah Vchesed Inc. - SCHEDULE 13D Activist Investment

SC 13D 1 ea122401-13dcongregatnovint.htm SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 NOVINT TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 670085103 (CUSIP Number) Congregation Ahavas Tzdokah Vchesed Inc. 1347 42nd Street Brooklyn, NY 11219 (718) 435-0959

May 26, 2020 SC 13D/A

NVNT / Novint Technologies, Inc. / Christoff Ryan - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment

SC 13D/A 1 ea122295-13da1christoffnovi.htm AMENDMENT NO. 1 TO SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment #1) * NOVINT TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 670085109 (CUSIP Number) Ryan Christoff 100 Merrick Road, Suite 400W Rockvill

May 14, 2020 10-Q

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-51783 NOVINT TECHNO

May 7, 2020 10-K

Novint Technologies, Inc. 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SPECIAL REPORT ON FORM 10-K (Mark One) ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended December 31, 2019 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File No. 000-51783 NOV

February 12, 2020 ORDER

NVNT / Novint Technologies, Inc. ORDER - -

begin 644 filename1 M)5!$1BTQ+C<-"B6AL\77#0HQ(# @;V)J#0H\/"]086=E<\$S[,@7?1,QR7C,=R9(WWWV\P$$]>7/0/T MGUSU^H]1F 932%(#1*8S\!".

February 10, 2020 CORRESP

NVNT / Novint Technologies, Inc. CORRESP - -

NOVINT TECHNOLOGIES, INC. 100 Merrick Road–Suite 400W Rockville Centre, NY 11570 February 11, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Attention: Michael Foland, Esq. Re: Novint Technologies, Inc. Registration Statement on Form 10-12G File No. 000-51783 REQUEST FOR ACCELERATION OF EFFECTIVENESS Gentlepersons: Pu

January 23, 2020 RW

NVNT / Novint Technologies, Inc. RW - - REGISTRATION WITHDRAWAL REQUEST

NOVINT TECHNOLOGIES, INC. 100 Merrick Road–Suite 400W Rockville Centre, NY 11570 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549-4628 Attention: Division of Corporation Finance Re: Novint Technologies, Inc. Registration Statement on Form 10-12G/A Filed January 22, 2020 File No. 000-51783 Ladies and Gentlemen: Novint Technologies, Inc. (the “Company“) hereby req

January 23, 2020 EX-3.1

Novint Technologies 10-12G

Novint Technologies 10-12G Exhibit 3.1

January 23, 2020 10-12G

NVNT / Novint Technologies, Inc. 10-12G - - GENERAL FORM FOR REGISTRATION OF SECURITIES

10-12G 1 nvnt-1012g012220.htm GENERAL FORM FOR REGISTRATION OF SECURITIES UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 NOVINT TECHNOLOGIES, INC. (name of small business issuer in its charter) Delaware 85-0461778 (State or other jurisdiction of incor

January 22, 2020 10-12G/A

NVNT / Novint Technologies, Inc. 10-12G/A - - AMENDMENT TO FORM 10-12G

10-12G/A 1 nvnt-1012ga011420.htm AMENDMENT TO FORM 10-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 NOVINT TECHNOLOGIES, INC. (name of small business issuer in its charter) Delaware 85-0461778 (State or other jurisdiction of incorporation or orga

January 22, 2020 EX-3.1

Novint Technologies 10-12G/A

Novint Technologies 10-12G/A Exhibit 3.1

January 21, 2020 CORRESP

NVNT / Novint Technologies, Inc. CORRESP - -

January 21, 2020 United Stated Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, DC 20549 Re: Novint Technologies, Inc.

January 7, 2020 RW

NVNT / Novint Technologies, Inc. RW - - REGISTRATION WITHDRAWAL REQUEST

NOVINT TECHNOLOGIES, INC. 100 Merrick Road–Suite 400W Rockville Centre, NY 11570 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549-4628 Attention: Division of Corporation Finance Re: Novint Technologies, Inc. Registration Statement on Form 10-12G Filed November 14, 2019 File No. 000-51783 Ladies and Gentlemen: Novint Technologies, Inc. (the “Company“) hereby requ

December 6, 2019 TEXT-EXTRACT

NVNT / Novint Technologies, Inc. TEXT-EXTRACT - -

December 6, 2019 Orin Hirschman President Novint Technologies, Inc. 100 Merrick Road, Suite 400W Rockville Centre, NY 11570 Re: Novint Technologies Inc. Registration Statement on Form 10-12G Filed November 14, 2019 File No. 000-51783 Dear Mr. Hirschman: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may bet

December 6, 2019 LETTER

LETTER

December 6, 2019 Orin Hirschman President Novint Technologies, Inc. 100 Merrick Road, Suite 400W Rockville Centre, NY 11570 Re: Novint Technologies Inc. Registration Statement on Form 10-12G Filed November 14, 2019 File No. 000-51783 Dear Mr. Hirschman: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may bet

November 14, 2019 10-12G

NVNT / Novint Technologies, Inc. 10-12G - - GENERAL FORM FOR REGISTRATION OF SECURITIES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10 GENERAL FORM FOR REGISTRATION OF SECURITIES Pursuant to Section 12(b) or (g) of The Securities Exchange Act of 1934 NOVINT TECHNOLOGIES, INC. (name of small business issuer in its charter) Delaware 85-0461778 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 100 Merrick

December 22, 2011 15-12G

OMB APPROVAL

OMB APPROVAL OMB Number: 3235-0167 Expires: October 31, 2013 Estimated average burden hours per response 1.

October 28, 2011 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): 10/28/2011 Novint Technologies, Inc. (Exact name of registrant as specified in its charter) Commission File Number: 00-51783 Delaware 85-0461778 (State or other jurisdiction of (IRS E

July 7, 2011 SC 13D

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 NOVINT TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 670085109 (CUSIP Number) Ryan Christoff 480 Johnson Road, Suite 303 Washington, PA 15301 (724) 223-4061 (Tel) (Name, Address and Telephone Number of Person Authorized to Rec

April 11, 2011 EX-99.1

Novint Technologies and ForceTek Enterprises Merge ForceTek Brings Capital and Stunning New Exoskeleton Technology, Giving Motion Control a Sense of Touch

EX-99.1 4 v218101ex99-1.htm PRESS RELEASE, DATED APRIL 11, 2011 Novint Technologies and ForceTek Enterprises Merge ForceTek Brings Capital and Stunning New Exoskeleton Technology, Giving Motion Control a Sense of Touch (Albuquerque, NM, April 11, 2011): Novint Technologies, Inc. (OTC Pink: NVNT) today announced the completion of Novint’s merger with ForceTek Enterprises, LLC. Novint will be combin

April 11, 2011 EX-10.2

ARTICLE I

EX-10.2 3 v218101ex10-2.htm AGREEMENT, DATED APRIL 6, 2009 AGREEMENT THIS AGREEMENT, dated April, 6th 2009, is made by and among INVERSE TECHNOLOGY CORPORATION, a Delaware corporation, having a place of business at 5540 South Street, Suite 208, Lincoln, Nebraska 68506, United States of America, (hereinafter referred to as "INVERSE"); KINETECS, INC., a Nebraska corporation, having a place of busine

April 11, 2011 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 11, 2011 (March 31, 2011) NOVINT TECHNOLOGIES, INC. (Exact name of registrant as specified in Charter) Delaware 000-51783 85-0461778 (State or other jurisdiction of incorporatio

April 11, 2011 EX-10.1

STOCK PURCHASE AND MERGER AGREEMENT

STOCK PURCHASE AND MERGER AGREEMENT This STOCK PURCHASE AND MERGER AGREEMENT is made as of the 31st day of March, 2011 by and among Novint Technologies, Inc.

February 8, 2011 LETTER

LETTER

February 8, 2011 Mr. Tom Anderson President, Chief Executive Officer and Chief Financial Officer Novint Technologies, Inc. 4109 Bryan Avenue, NW Albuquerque, NM 87114 Re: Novint Technologies, Inc. Form 10-K/A for the Fiscal Year Ended December 31, 2008 Filed April 23, 2009 File No. 000-51783 Dear Mr. Anderson: We have completed our review of your Form 10-K and related filings and have no further c

January 25, 2011 CORRESP

RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, CA 90024 Telephone (310) 208-1182 Facsimile (310) 208-1154 January 25, 2011

CORRESP 1 filename1.htm RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, CA 90024 Telephone (310) 208-1182 Facsimile (310) 208-1154 January 25, 2011 Mr. Patrick Gilmore Accounting Branch Chief Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Novint Technologies, Inc. Form 10-K/A for the Fiscal Year Ended December 3

January 10, 2011 LETTER

LETTER

January 10, 2011 Mr. Tom Anderson President, Chief Executive Officer and Chief Financial Officer Novint Technologies, Inc. 4109 Bryan Avenue, NW Albuquerque, NM 87114 Re: Novint Technologies, Inc. Form 10-K/A for the Fiscal Year Ended December 31, 2008 Filed April 23, 2009 Form 10-Q for the Quarterly Period Ended September 30, 2009 Filed November 23, 2009 File No. 000-51783 Dear Mr. Anderson: We h

December 8, 2010 CORRESP

RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, CA 90024 Telephone (310) 208-1182 Facsimile (310) 208-1154 December 8, 2010

RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, CA 90024 Telephone (310) 208-1182 Facsimile (310) 208-1154 December 8, 2010 Mr.

November 19, 2010 CORRESP

RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, CA 90024 Telephone (310) 208-1182 Facsimile (310) 208-1154 November 19, 2010

RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, CA 90024 Telephone (310) 208-1182 Facsimile (310) 208-1154 November 19, 2010 Mr.

November 4, 2010 LETTER

LETTER

November 4, 2010 Mr. Tom Anderson President, Chief Executive Officer and Chief Financial Officer Novint Technologies, Inc. 4601 Paradise Blvd., NW, Suite B Albuquerque, NM 87114 Re: Novint Technologies, Inc. Form 10-K/A for the Fiscal Year Ended December 31, 2008 Filed April 23, 2009 Form 10-Q for the Quarterly Period Ended September 30, 2009 Filed November 23, 2009 File No. 000-51783 Dear Mr. And

October 19, 2010 CORRESP

RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, CA 90024 Telephone (310) 208-1182 Facsimile (310) 208-1154 October 19, 2010

RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, CA 90024 Telephone (310) 208-1182 Facsimile (310) 208-1154 October 19, 2010 Mr.

October 6, 2010 LETTER

LETTER

October 5, 2010 Mr. Tom Anderson President, Chief Executive Officer and Chief Financial Officer Novint Technologies, Inc. 4601 Paradise Blvd., NW, Suite B Albuquerque, NM 87114 Re: Novint Technologies, Inc. Form 10-K/A for the Fiscal Year Ended December 31, 2008 Filed April 23, 2009 File No. 000-51783 Dear Mr. Anderson: We have reviewed your letter dated August 31, 2010 in connection with the abov

August 31, 2010 CORRESP

CORRESP

August 31, 2010 CORRESP

RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, CA 90024 Telephone (310) 208-1182 Facsimile (310) 208-1154 August 31, 2010

RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, CA 90024 Telephone (310) 208-1182 Facsimile (310) 208-1154 August 31, 2010 Mr.

August 19, 2010 LETTER

LETTER

August 17, 2010 Mr. Tom Anderson President, Chief Executive Officer and Chief Financial Officer Novint Technologies, Inc. 4601 Paradise Blvd., NW, Suite B Albuquerque, NM 87114 Re: Novint Technologies, Inc. Form 10-K/A for the Fiscal Year Ended December 31, 2008 Filed April 23, 2009 File No. 000-51783 Dear Mr. Anderson: We have reviewed your filing and have the following comments. In some of our c

March 15, 2010 SC 13G

SCHEDULE 13G Novint Technology Inc. SIGNATURE

OMB APPROVAL OMB Number: 3235-0145 Expires: January 31, 2011 Estimated average burden hours per response.

February 11, 2010 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 3)*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 3)* NOVINT TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 670085109 (CUSIP Number) December 31, 2009 (Date of Event which requires Filing of

February 2, 2010 SC 13G

SCHEDULE 13G SIGNATURE

OMB APPROVAL OMB Number: 3235-0145 Expires: January 31, 2010 Estimated average burden hours per response.

November 23, 2009 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2009 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 000-51783 NOVINT TECHNOLOGIES, INC. (Exact name of regi

November 16, 2009 NT 10-Q

NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 000-51783 (Check One): || Form 10-K || Form 20-F || Form 11-K |X| Form 10-Q || Form N-SAR || Form N-CSR For Period Ended: September 30, 2009 || Transition Report on Form 10-K || Transition Report on Form 20-F || Transition Report on Form 11-K || Transition Report on Form 10-Q || Transition Report on Form N-SAR For the Transition Period Ended: Read attached instruction sheet before preparing form.

August 19, 2009 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2009 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 000-51783 NOVINT TECHNOLOGIES, INC. (Exact name of registran

August 14, 2009 NT 10-Q

NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 000-51783 (Check One): || Form 10-K || Form 20-F || Form 11-K |X| Form 10-Q || Form N-SAR || Form N-CSR For Period Ended: June 30, 2009 || Transition Report on Form 10-K || Transition Report on Form 20-F || Transition Report on Form 11-K || Transition Report on Form 10-Q || Transition Report on Form N-SAR For the Transition Period Ended: Read attached instruction sheet before preparing form.

May 15, 2009 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2009 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 000-51783 Novint Technologies, Inc. (Exact name of registra

April 23, 2009 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2008 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-51783 NOVINT TECHNOLOGIES, IN

April 16, 2009 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2008 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-51783 NOVINT TECHNOLOGIES, INC.

April 16, 2009 EX-10.27

NOVINT TECHNOLOGIES, INC. SENIOR SECURED PROMISSORY NOTE Due February __, 2010

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF.

April 16, 2009 EX-10.29

NOVINT TECHNOLOGIES, INC. COMMON STOCK PURCHASE WARRANT

NOVINT TECHNOLOGIES, INC. COMMON STOCK PURCHASE WARRANT (?WARRANT?) Warrant No. Warrants VOID AFTER 5:00 P.M. ALBUQUERQUE TIME On February , 2014 THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE

April 16, 2009 EX-10.26

SUBSCRIPTION AGREEMENT

SUBSCRIPTION AGREEMENT This SUBSCRIPTION AGREEMENT ("Subscription Agreement") is made and entered into as of February , 2009 by and among Novint Technologies, Inc.

April 16, 2009 EX-10.30

INTERCREDITOR AGREEMENT

INTERCREDITOR AGREEMENT This INTERCREDITOR AGREEMENT, dated as of December 4, 2008 (this ?Agreement?), is entered into by and among the noteholders whose names and addresses are set forth on the signature pages hereto (the ?Noteholders?).

April 16, 2009 EX-10.28

NOVINT TECHNOLOGIES, INC. 5% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE Due February __, 2011

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF.

March 31, 2009 NT 10-K

NT 10-K

NT 10-K 1 v144799nt-10k.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 000-51783 (Check One): |X| Form 10-K || Form 20-F || Form 11-K || Form 10-Q || Form N-SAR || Form N-CSR For Period Ended: December 31, 2008 || Transition Report on Form 10-K || Transition Report on Form 20-F || Transition Report on Form 1

February 17, 2009 SC 13G/A

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 4)1 Novint Technologies Inc. (Name of Issuer) Common Shares (Title o

SC 13G/A 1 rabsc13ganovint-123108.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 4)1 Novint Technologies Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 670085109 (CUSIP Number) December 31, 2008 (Date of Event Which Requires Filing of This S

February 13, 2009 SC 13G

SCHEDULE 13G SIGNATURE

OMB APPROVAL OMB Number: 3235-0145 Expires: January 31, 2009 Estimated average burden hours per response.

February 13, 2009 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 2 )* NOVINT TECHNOLOGIES, INC. (Name of Issuer) Comm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 2 )* NOVINT TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 670085109 (CUSIP Number) December 31, 2008 (Date of Event which requires Filing o

December 9, 2008 EX-4.1

NOVINT TECHNOLOGIES, INC. 8% SENIOR SECURED PROMISSORY NOTE Due December 4, 2009

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF.

December 9, 2008 EX-4.3

NOVINT TECHNOLOGIES, INC. COMMON STOCK PURCHASE WARRANT

NOVINT TECHNOLOGIES, INC. COMMON STOCK PURCHASE WARRANT (?WARRANT?) Warrant No. Warrants VOID AFTER 5:00 P.M. ALBUQUERQUE TIME On December4, 2013 THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE

December 9, 2008 EX-4.2

NOVINT TECHNOLOGIES, INC. 10% SENIOR SECURED CONVERTIBLE PROMISSORY NOTE Due December 4, 2010

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF.

December 9, 2008 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 9, 2008 (December 4, 2008) NOVINT TECHNOLOGIES, INC.

December 9, 2008 EX-10.2

INTERCREDITOR AGREEMENT

INTERCREDITOR AGREEMENT This INTERCREDITOR AGREEMENT, dated as of December 4, 2008 (this ?Agreement?), is entered into by and among the noteholders whose names and addresses are set forth on the signature pages hereto (the ?Noteholders?).

December 9, 2008 EX-10.1

SUBSCRIPTION PROCEDURE To Subscribe for Notes and Warrants of Novint Technologies, Inc.

SUBSCRIPTION PROCEDURE To Subscribe for Notes and Warrants of Novint Technologies, Inc.

November 19, 2008 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED September 30, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 000-51783 Novint Technologies, Inc. (Exact name of smal

November 14, 2008 NT 10-Q

NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (CHECK ONE): || Form 10-K || Form 20-F || Form 11-K |X| Form 10-Q || Form 10-D || Form N-SAR For Period ended: September 30, 2008 || Transition Report on Form 10-K || Transition Report on Form 20-F || Transition Report on Form 11-K || Transition Report on Form 10-Q || Transition Report o

August 14, 2008 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 000-51783 Novint Technologies, Inc. (Exact name of small bus

June 16, 2008 DEF 14A

UNITED STATES

DEF 14A 1 v117240def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 DEFINITIVE SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as perm

June 13, 2008 EX-4.2

NOVINT TECHNOLOGIES, INC. FORM OF COMMON STOCK PURCHASE WARRANT Warrant No. ________ _________ Warrants VOID AFTER 5:00 P.M. LOS ANGELES TIME ON ___________, 2013

EX-4.2 3 v117234ex4-2.htm NOVINT TECHNOLOGIES, INC. FORM OF COMMON STOCK PURCHASE WARRANT Warrant No. Warrants VOID AFTER 5:00 P.M. LOS ANGELES TIME ON , 2013 THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO

June 13, 2008 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2008 (June 9, 2008) NOVINT TECHNOLOGIES, INC.

June 13, 2008 EX-10.1

SUBSCRIPTION PROCEDURE To Subscribe for Notes and Warrants of Novint Technologies, Inc.:

EX-10.1 4 v117234ex10-1.htm SUBSCRIPTION PROCEDURE To Subscribe for Notes and Warrants of Novint Technologies, Inc.: 1. Date and Fill In the amount of Notes and Warrants being subscribed to and Complete and Sign the Subscription Agreement on the applicable Signature Page. 2. Fax the signed Subscription Agreement to, and send all signed originals to and form of payment to: Novint Technologies, Inc.

June 13, 2008 EX-4.1

NOVINT TECHNOLOGIES, INC. FORM OF UNSECURED CONVERTIBLE NOTE DUE ____________, 2011

EX-4.1 2 v117234ex4-1.htm THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE MAKER OF AN OPINION OF COUNSEL IN THE FORM, SUBSTANCE AND SCOPE REASONABLY SATIS

May 15, 2008 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File No. 000-51783 Novint Technologies, Inc. (Exac

May 12, 2008 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2008 (May 6, 2008) NOVINT TECHNOLOGIES, INC.

May 12, 2008 EX-4.2

NOVINT TECHNOLOGIES, INC. FORM OF COMMON STOCK PURCHASE WARRANT Warrant No. ________ _________ Warrants VOID AFTER 5:00 P.M. LOS ANGELES TIME ON ___________, 2013

EX-4.2 3 v113642ex4-2.htm NOVINT TECHNOLOGIES, INC. FORM OF COMMON STOCK PURCHASE WARRANT Warrant No. Warrants VOID AFTER 5:00 P.M. LOS ANGELES TIME ON , 2013 THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO

May 12, 2008 EX-4.1

NOVINT TECHNOLOGIES, INC. FORM OF UNSECURED CONVERTIBLE NOTE DUE ____________, 2011

EX-4.1 2 v113642ex4-1.htm THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE MAKER OF AN OPINION OF COUNSEL IN THE FORM, SUBSTANCE AND SCOPE REASONABLY SATIS

May 12, 2008 EX-10.1

SUBSCRIPTION PROCEDURE To Subscribe for Notes and Warrants of Novint Technologies, Inc.:

SUBSCRIPTION PROCEDURE To Subscribe for Notes and Warrants of Novint Technologies, Inc.

April 15, 2008 EX-4.1

NOVINT TECHNOLOGIES, INC. FORM OF UNSECURED CONVERTIBLE NOTE DUE ____________, 2011

EX-4.1 2 v110797ex4-1.htm THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE MAKER OF AN OPINION OF COUNSEL IN THE FORM, SUBSTANCE AND SCOPE REASONABLY SATIS

April 15, 2008 EX-4.2

NOVINT TECHNOLOGIES, INC. FORM OF COMMON STOCK PURCHASE WARRANT Warrant No. ________ _________ Warrants VOID AFTER 5:00 P.M. LOS ANGELES TIME ON ___________, 2013

EX-4.2 3 v110797ex4-2.htm NOVINT TECHNOLOGIES, INC. FORM OF COMMON STOCK PURCHASE WARRANT Warrant No. Warrants VOID AFTER 5:00 P.M. LOS ANGELES TIME ON , 2013 THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO

April 15, 2008 8-K

Entry into a Material Definitive Agreement

\ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2008 NOVINT TECHNOLOGIES, INC.

April 15, 2008 EX-10.1

SUBSCRIPTION PROCEDURE To Subscribe for Notes and Warrants of Novint Technologies, Inc.:

EX-10.1 4 v110797ex10-1.htm SUBSCRIPTION PROCEDURE To Subscribe for Notes and Warrants of Novint Technologies, Inc.: 1. Date and Fill In the amount of Notes and Warrants being subscribed to and Complete and Sign the Subscription Agreement on the applicable Signature Page. 2. Fax the signed Subscription Agreement to, and send all signed originals to and form of payment to: Novint Technologies, Inc.

April 9, 2008 10KSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2007 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-51783 NOVINT TECHNOLOGIES, IN

April 1, 2008 NT 10-K

NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (CHECK ONE): |X| Form 10-K || Form 20-F || Form 11-K ||Form 10-Q || Form 10-D || Form N-SAR For Period ended: December 31, 2007 || Transition Report on Form 10-K || Transition Report on Form 20-F || Transition Report on Form 11-K || Transition Report on Form 10-Q || Transition Report on

March 13, 2008 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2008 NOVINT TECHNOLOGIES, INC.

March 3, 2008 SC 13G

SCHEDULE 13G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 NOVINT TECHNOLOGIES, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $.01 PER SHARE (Title of Class of Securities) 670085109 (CUSIP Number) December 31, 2007 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w

February 11, 2008 SC 13G/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1)*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1)* NOVINT TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 670085109 (CUSIP Number) December 31, 2007 (Date of Event which requires Filing of

February 7, 2008 SC 13G/A

SCHEDULE 13G (Rule 13d-102)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION STATEMENT PURSUANT TO RULES 13D-1 AND 13D-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO.

November 16, 2007 424B3

Prospectus Supplement No. 2 dated November 16, 2007 (To Prospectus dated June 18, 2007 and filed on June 19, 2007 - File No. 333-143234) NOVINT TECHNOLOGIES, INC. 20,136,113 shares of Common Stock

424B3 1 v094717424b3.htm Filed Pursuant to Rule 424(b)(3) Registration No. 333-143234 Prospectus Supplement No. 2 dated November 16, 2007 (To Prospectus dated June 18, 2007 and filed on June 19, 2007 - File No. 333-143234) NOVINT TECHNOLOGIES, INC. PROSPECTUS 20,136,113 shares of Common Stock This Prospectus Supplement, together with the Prospectus listed above, is required to be delivered by cert

November 16, 2007 424B3

Prospectus Supplement No. 2 dated November 16, 2007 (To Prospectus dated August 13, 2007 and filed on August 13, 2007 - File No. 333-115548) NOVINT TECHNOLOGIES, INC. 20,136,113 shares of Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-115548 Prospectus Supplement No. 2 dated November 16, 2007 (To Prospectus dated August 13, 2007 and filed on August 13, 2007 - File No. 333-115548) NOVINT TECHNOLOGIES, INC. PROSPECTUS 20,136,113 shares of Common Stock This Prospectus Supplement, together with the Prospectus listed above, is required to be delivered by certain holders of the ab

November 15, 2007 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (CHECK ONE): o Form 10-K o Form 20-F o Form 11-K ý Form 10-Q o Form 10-D o Form N-SAR For Period ended: September 30, 2007 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form N-SAR

November 15, 2007 10QSB

United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB

United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2007 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-51783 NOVINT TECHNOLOGIES, INC. (Name of Small Business Issuer in its Ch

August 15, 2007 424B3

Prospectus Supplement dated August 15, 2007 (To Prospectus dated August 13, 2007 and filed on August 13, 2007 — File No. 333-115548) NOVINT TECHNOLOGIES, INC. 3,192,900 shares of Common Stock

424B3 1 a33063b3e424b3.htm 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-115548 Prospectus Supplement dated August 15, 2007 (To Prospectus dated August 13, 2007 and filed on August 13, 2007 — File No. 333-115548) NOVINT TECHNOLOGIES, INC. PROSPECTUS 3,192,900 shares of Common Stock This Prospectus Supplement, together with the Prospectus listed above, is required to be delivered by c

August 15, 2007 424B3

Prospectus Supplement dated August 15, 2007 (To Prospectus dated June 18, 2007 and filed on June 19, 2007 ? File No. 333-143234) NOVINT TECHNOLOGIES, INC. 20,136,113 shares of Common Stock

424B3 1 a33064b3e424b3.htm 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-143234 Prospectus Supplement dated August 15, 2007 (To Prospectus dated June 18, 2007 and filed on June 19, 2007 — File No. 333-143234) NOVINT TECHNOLOGIES, INC. PROSPECTUS 20,136,113 shares of Common Stock This Prospectus Supplement, together with the Prospectus listed above, is required to be delivered by cert

August 14, 2007 10QSB

United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB þ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2007 o TRANSITION REPORT UNDER SECTION 13

Table of Contents United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2007 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-51783 NOVINT TECHNOLOGIES, INC. (Name of Small Business Iss

August 13, 2007 424B3

Prospectus Novint Technologies, Inc. 3,192,900 Shares of Common Stock

424B3 1 a32689b3e424b3.htm PROSPECTUS Table of Contents This filing is made pursuant to Rule 424(b)(3) under the Securities Act of 1933 in connection with Registration No. 333-115548 Prospectus Novint Technologies, Inc. 3,192,900 Shares of Common Stock This prospectus covers the resale by selling shareholders named on page 34 of up to 3,192,900 shares of our common stock which include: • 415,000 s

August 9, 2007 POS AM

As filed with the Securities and Exchange Commission on August 8, 2007

posam Table of Contents As filed with the Securities and Exchange Commission on August 8, 2007 Registration Statement No.

August 9, 2007 10KSB/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB/A þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

e10ksbza UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB/A þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2006 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-51783 NOVINT TECHN

August 8, 2007 CORRESP

August 8, 2007

August 8, 2007 VIA FACSIMILE AND EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F.

August 3, 2007 LETTER

COMMENT LETTER DATED AUGUST 3, 2007 | POS AM NO. 1 TO FORM SB-2 (333-115548) | SHUMAN/ORLIC

Mail Stop 4561 August 3, 2007 Thomas G. Anderson Chief Executive Officer Novint Technologies, Inc. 4109 Bryan Avenue, NW Albuquerque, New Mexico 87114 Re: Novint Technologies, Inc. Post-Effective Amdt. No. 1 to Registration Statement on Form SB-2 Filed on July 27, 2007 File No. 333-115548 Form 10-KSB for Fiscal Year Ended December 31, 2006 File No. 000-51783 Ladies and Gentlemen: We have limited o

July 27, 2007 POS AM

As filed with the Securities and Exchange Commission on July 27, 2007

Table of Contents As filed with the Securities and Exchange Commission on July 27, 2007 Registration Statement No.

July 27, 2007 EX-10.54

10.54 (12)

CALIFORNIA ASSOCIATION OF REALTORS Date (For reference only): June 21, 2007 Floit Properties, Inc.

July 27, 2007 EX-10.53

10.53 (12)

exv10w53 EXHIBIT 10.53 LEASE between Novint Technologies, Inc. a DE corporation as Tenant and The Shops at Westpark, LLC A New Mexico limited liability company as Landlord dated May 29, 2007 LEASE This LEASE is made as of the 29th day of May, 2007, by and between The Shops at Westpark, L C, a New Mexico limited liability company (“Landlord”), and Novint Technologies, Inc., a DE corporation (“Tenan

July 23, 2007 EX-10.1

10.52 (11)

Exhibit 10.1 Novint/Tournabout Intellectual Property Acquisition Agreement This Intellectual Property Acquisition Agreement (this ?Agreement?) is between Novint Technologies, Inc., a Delaware corporation having offices in Albuquerque, NM (?Novint?) and Tournabout, Inc., a California corporation having offices in Carpinteria, CA (?Tournabout?), and is effective as of April 21, 2007 (the ?Effective

July 23, 2007 EX-99.1

Novint Technologies Acquires Tournabout Incorporated

Exhibit 99.1 Novint Technologies Acquires Tournabout Incorporated Wednesday July 18, 9:00 am ET Acquisition Brings Community Aspect To Falcon Flock ALBUQUERQUE, N.M.?(BUSINESS WIRE)?Novint Technologies, Inc. (OTCBB:NVNT ? News), the pioneer of 3D touch for consumer computing, announces the acquisition of Tournabout Incorporated, which develops and markets video game contest and community infrastru

July 23, 2007 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

8-K 1 a32080e8vk.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2007 (July 17, 2007) NOVINT TECHNOLOGIES, INC. (Exact name of Registrant as specified in charter) Delaware (State or other jurisdiction of incorp

June 27, 2007 S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NOVINT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdi

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NOVINT TECHNOLOGIES, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 85-0461778 (I.R.S. Employer Identification No.) 4109 Bryan Avenue, NW Albuquerque, New Mexic

June 27, 2007 EX-4.1

EXHIBIT 4.1

Exhibit 4.1 NOVINT TECHNOLOGIES, INC. AMENDED AND RESTATED 2004 STOCK INCENTIVE PLAN ARTICLE ONE GENERAL PROVISIONS I. PURPOSE OF THE PLAN This Amended and Restated 2004 Stock Incentive Plan (the ?Plan?) is intended to promote the interests of Novint Technologies, Inc., a Delaware corporation (the ?Corporation?) by providing eligible persons with the opportunity to acquire a proprietary interest,

June 21, 2007 EX-3.1

3.1 (9)

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NOVINT TECHNOLOGIES, INC. Novint Technologies, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), certifies that: A. The name of the Corporation is: Novint Technologies, Inc. The Corporation?s original Certificate of Incorporation was filed with the Secretary of State of the State

June 21, 2007 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2007 (June 20, 2007) NOVI

e8vk UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2007 (June 20, 2007) NOVINT TECHNOLOGIES, INC.

June 19, 2007 424B3

Novint Technologies, Inc. 20,136,113 Shares of Common Stock

Table of Contents This filing is made pursuant to Rule 424(b)(3) under the Securities Act of 1933 in connection with Registration No.

May 24, 2007 EX-10.5

NOVINT TECHNOLOGIES, INC. AMENDED AND RESTATED 2004 STOCK INCENTIVE PLAN ARTICLE ONE GENERAL PROVISIONS

Exhibit 10.5 NOVINT TECHNOLOGIES, INC. AMENDED AND RESTATED 2004 STOCK INCENTIVE PLAN ARTICLE ONE GENERAL PROVISIONS I. PURPOSE OF THE PLAN This Amended and Restated 2004 Stock Incentive Plan (the ?Plan?) is intended to promote the interests of Novint Technologies, Inc., a Delaware corporation (the ?Corporation?) by providing eligible persons with the opportunity to acquire a proprietary interest,

May 24, 2007 SB-2

As filed with the Securities and Exchange Commission on May 24, 2007

Table of Contents As filed with the Securities and Exchange Commission on May 24, 2007 Registration Statement No.

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista